-
Something wrong with this record ?
Honey flavonoids inhibit hOATP2B1 and hOATP1A2 transporters and hOATP-mediated rosuvastatin cell uptake in vitro
L. Navrátilová, J. Ramos Mandíková, P. Pávek, P. Mladěnka, F. Trejtnar,
Language English Country England, Great Britain
Document type Journal Article
- MeSH
- Models, Biological MeSH
- Madin Darby Canine Kidney Cells MeSH
- Diet MeSH
- Flavonoids pharmacology MeSH
- HEK293 Cells MeSH
- Inhibitory Concentration 50 MeSH
- Humans MeSH
- Honey * MeSH
- Organic Anion Transporters antagonists & inhibitors metabolism MeSH
- Dogs MeSH
- Rosuvastatin Calcium metabolism MeSH
- Transfection MeSH
- Protein Transport drug effects MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Dogs MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
1. Some flavonoids contained in the common diet have been shown to interact with important membrane uptake transporters, including organic anion transporting polypeptides (OATPs). OATP2B1 and OATP1A2 expressed in the apical membrane of human enterocytes may significantly contribute to the intestinal absorption of drugs, e.g. statins. This study is aimed at an evaluation of the inhibitory potency of selected food honey flavonoids (namely galangin, myricetin, pinocembrin, pinobanksin, chrysin and fisetin) toward hOATP2B1 and hOATP1A2 as well as at examining their effect on the cellular uptake of the known OATP substrate rosuvastatin. 2. Cell lines overexpressing the hOATP2B1 or hOATP1A2 transporter were employed as in vitro model to determine the inhibitory potency of the flavonoids toward the OATPs. 3. Chrysin, galangin and pinocembrin were found to inhibit both hOATP2B1 and hOATP1A2 in lower or comparable concentrations as the known flavonoid OATP inhibitor quercetin. Galangin, chrysin and pinocembrin effectively inhibited rosuvastatin uptake by hOATP2B1 with IC50 ∼1-10 μM. The inhibition of the hOATP1A2-mediated transport of rosuvastatin by these flavonoids was weaker. 4. The found data indicate that several of the tested natural compounds could potentially affect drug cellular uptake by hOATP2B1 and/or hOATP1A2 at relative low concentrations, a finding which suggests their potential for food-drug interactions.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033808
- 003
- CZ-PrNML
- 005
- 20181012111031.0
- 007
- ta
- 008
- 181008s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/00498254.2017.1358469 $2 doi
- 035 __
- $a (PubMed)28745105
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Navrátilová, Lucie $u a Department of Pharmacology and Toxicology , Faculty of Pharmacy in Hradec Králové, Charles University , Hradec Králové , Czech Republic.
- 245 10
- $a Honey flavonoids inhibit hOATP2B1 and hOATP1A2 transporters and hOATP-mediated rosuvastatin cell uptake in vitro / $c L. Navrátilová, J. Ramos Mandíková, P. Pávek, P. Mladěnka, F. Trejtnar,
- 520 9_
- $a 1. Some flavonoids contained in the common diet have been shown to interact with important membrane uptake transporters, including organic anion transporting polypeptides (OATPs). OATP2B1 and OATP1A2 expressed in the apical membrane of human enterocytes may significantly contribute to the intestinal absorption of drugs, e.g. statins. This study is aimed at an evaluation of the inhibitory potency of selected food honey flavonoids (namely galangin, myricetin, pinocembrin, pinobanksin, chrysin and fisetin) toward hOATP2B1 and hOATP1A2 as well as at examining their effect on the cellular uptake of the known OATP substrate rosuvastatin. 2. Cell lines overexpressing the hOATP2B1 or hOATP1A2 transporter were employed as in vitro model to determine the inhibitory potency of the flavonoids toward the OATPs. 3. Chrysin, galangin and pinocembrin were found to inhibit both hOATP2B1 and hOATP1A2 in lower or comparable concentrations as the known flavonoid OATP inhibitor quercetin. Galangin, chrysin and pinocembrin effectively inhibited rosuvastatin uptake by hOATP2B1 with IC50 ∼1-10 μM. The inhibition of the hOATP1A2-mediated transport of rosuvastatin by these flavonoids was weaker. 4. The found data indicate that several of the tested natural compounds could potentially affect drug cellular uptake by hOATP2B1 and/or hOATP1A2 at relative low concentrations, a finding which suggests their potential for food-drug interactions.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a dieta $7 D004032
- 650 _2
- $a psi $7 D004285
- 650 _2
- $a flavonoidy $x farmakologie $7 D005419
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 12
- $a med $7 D006722
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inhibiční koncentrace 50 $7 D020128
- 650 _2
- $a buňky MDCK $7 D061985
- 650 _2
- $a biologické modely $7 D008954
- 650 _2
- $a přenašeče organických aniontů $x antagonisté a inhibitory $x metabolismus $7 D027361
- 650 _2
- $a transport proteinů $x účinky léků $7 D021381
- 650 _2
- $a rosuvastatin kalcium $x metabolismus $7 D000068718
- 650 _2
- $a transfekce $7 D014162
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ramos Mandíková, Jana $u a Department of Pharmacology and Toxicology , Faculty of Pharmacy in Hradec Králové, Charles University , Hradec Králové , Czech Republic.
- 700 1_
- $a Pávek, Petr $u a Department of Pharmacology and Toxicology , Faculty of Pharmacy in Hradec Králové, Charles University , Hradec Králové , Czech Republic.
- 700 1_
- $a Mladěnka, Přemysl $u a Department of Pharmacology and Toxicology , Faculty of Pharmacy in Hradec Králové, Charles University , Hradec Králové , Czech Republic.
- 700 1_
- $a Trejtnar, František $u a Department of Pharmacology and Toxicology , Faculty of Pharmacy in Hradec Králové, Charles University , Hradec Králové , Czech Republic.
- 773 0_
- $w MED00004746 $t Xenobiotica; the fate of foreign compounds in biological systems $x 1366-5928 $g Roč. 48, č. 7 (2018), s. 745-755
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28745105 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181012111523 $b ABA008
- 999 __
- $a ok $b bmc $g 1340306 $s 1030802
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 48 $c 7 $d 745-755 $e 20170818 $i 1366-5928 $m Xenobiotica $n Xenobiotica $x MED00004746
- LZP __
- $a Pubmed-20181008